Sullivan Christopher Ryan
- SEC CIK
- 0001810417
In the past year, 7 open-market sale filings worth $3.72M and no purchases.
Current role at each company
- AVTX Avalo Therapeutics, Inc.Chief Financial Officeras of Sep 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.72M
- 7 filings
- Net
- −$3.72M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sullivan Christopher Ryan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 (view filing)4:10 PM ET | Sep 16 | 2 days | Sullivan Christopher RyanChief Financial Officer | SSale | −12.4K | $16.33 | −$202.4K | −23.7%39.9K after | 10b5-1 |
| Sep 11, 2026 (view filing)4:10 PM ET | Sep 10 | 1 day | Sullivan Christopher RyanChief Financial Officer | SSale | −10.2K | $17.62 | −$179.5K | −20.3%39.9K after | 10b5-1 |
| Aug 19, 2026 (view filing)4:10 PM ET | Aug 17-18 | 2 days | Sullivan Christopher RyanChief Financial Officer | SSale | −72.7K | $19.94 | −$1.45M | −64.6%39.9K after | 3 lots10b5-1 |
| May 11, 2026 (view filing) | May 7 | 4 days | Sullivan Christopher RyanChief Financial Officer | SSale | −18.6K | $24.12 | −$448.8K | −97.8%423 after | 10b5-1 |
| May 7, 2026 (view filing) | May 6 | 1 day | Sullivan Christopher RyanChief Financial Officer | SSale | −47.0K | $20.18 | −$948.6K | −99.1%423 after | 5 lots10b5-1 |
| May 1, 2026 (view filing) | Apr 29-30 | 2 days | Sullivan Christopher RyanChief Financial Officer | SSale | −16.9K | $13.16 | −$222.6K | −97.6%423 after | 2 lots10b5-1 |
| Apr 3, 2026 (view filing) | Apr 1-2 | 2 days | Sullivan Christopher RyanChief Financial Officer | SSale | −16.0K | $16.96 | −$270.6K | −47.9%17.3K after | 4 lots10b5-1 |
| Jun 13, 2023 (view filing) | Jun 9 | 4 days | Sullivan Christopher RyanChief Financial Officer | PPurchase | +511 | $3.42 | +$1.75K | +68.0%1.26K after | |
| Dec 14, 2021 (view filing) | Dec 10 | 4 days | Sullivan Christopher RyanChief Accounting Officer | PPurchase | +955 | $1.57 | +$1.50K | +11.9%9.00K after |